Cuifu Yu
Impact in
-
- Cancer, Hypoxia, and Metabolism
-
- Ubiquitin and proteasome pathways
- Protein Degradation and Inhibitors
- RNA modifications and cancer
- Histone Deacetylase Inhibitors Research
Papers in
-
- Ubiquitin and proteasome pathways 10
- Protein Degradation and Inhibitors 4
- PI3K/AKT/mTOR signaling in cancer 2
- Histone Deacetylase Inhibitors Research 2
- Angiogenesis and VEGF in Cancer 1
-
- Cancer, Hypoxia, and Metabolism 2
- Co-authors
- Hongbiao Huang (13 shared papers)Xiaohong Xia (10 shared papers)Yuning Liao (11 shared papers)Zhenlong Shao (8 shared papers)Yuan Liu (6 shared papers)Jinchan He (6 shared papers)Jinbao Liu (5 shared papers)Ningning Liu (4 shared papers)
- Journals
- Cell Death and Disease (3 papers)International Journal of Biological Sciences (2 papers)Experimental Cell Research (1 paper)Frontiers in Pharmacology (1 paper)Acta Pharmacologica Sinica (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Cuifu Yu
14 papers receiving 332 citations
Peers
Comparison fields: 5 of 51
- Cancer Research 49
- Molecular Biology 242
- Oncology 86
- Cell Biology 33
- Immunology 28
Countries citing papers authored by Cuifu Yu
This map shows the geographic impact of Cuifu Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cuifu Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cuifu Yu more than expected).
Fields of papers citing papers by Cuifu Yu
This network shows the impact of papers produced by Cuifu Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cuifu Yu. The network helps show where Cuifu Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Cuifu Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 42 | |
| 2 | 2020 | 40 | |
| 3 | 2021 | 37 | |
| 4 | 2021 | 36 | |
| 5 | 2021 | 36 | |
| 6 | 2023 | 33 | |
| 7 | 2022 | 23 | |
| 8 | 2020 | 18 | |
| 9 | 2022 | 17 | |
| 10 | 2020 | 15 | |
| 11 | 2021 | 15 | |
| 12 | 2022 | 14 | |
| 13 | ERα is a target for butein-induced growth suppression in breast cancer. | 2020 | 7 |
| 14 | 2024 | 2 |
About Cuifu Yu
Cuifu Yu is a scholar working on Molecular Biology, Cancer Research, Cell Biology, Hematology and Oncology, having authored 14 papers that have together received 335 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (10 papers), Protein Degradation and Inhibitors (4 papers), Endoplasmic Reticulum Stress and Disease (3 papers), Estrogen and related hormone effects (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Histone Deacetylase Inhibitors Research (2 papers) and Angiogenesis and VEGF in Cancer (1 paper). The work is most often cited by research in Cancer Research (49 citations), Molecular Biology (242 citations), Oncology (86 citations), Cell Biology (33 citations) and Immunology (28 citations). Cuifu Yu has collaborated with scholars based in China and United States. Frequent co-authors include Hongbiao Huang, Xiaohong Xia, Yuning Liao, Zhenlong Shao, Yuan Liu, Jinchan He, Jinbao Liu, Ningning Liu, Qiong Xu and Daolin Tang. Their work appears in journals such as Cell Death and Disease, International Journal of Biological Sciences, Experimental Cell Research, Frontiers in Pharmacology and Acta Pharmacologica Sinica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.